Adult patients with an AML diagnosis (ICD-9-CM/ICD-10-CM) who achieved remission after first-line induction chemotherapy were identified from an administrative claims health database (Optum Clinformatics Data Mart). Additional inclusion/exclusion criteria were applied to match the QUAZAR AML-001 ...
Thirdly, we further aimed to evaluate whether there was a difference in baseline factors, treatment-related factors, TEAEs and the efficacy of azacitidine as front-line therapy for AML patients of the AAR who met clinical trial inclusion criteria (“AAR (001-like)” subset) versus all comers ...